logo
Select company
Select metric
$ 2.08MNet Cash Flow - Financing
VS
Market
42
Sector
60
Industry
69
History
86
$ 5.87Close
$ 5.02 - $ 21.59 52-Week Range
Ticker Information

Ticker

TRDA

Company Name

ENTRADA THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ENTRADA THERAPEUTICS INC - Net Cash Flow - Financing Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

TRDA - CF - Financing Historical data
DateNet Cash Flow - Financing
6/30/2025$ 2.08M
3/31/2025$ 103.11M
12/31/2024$ 102.96M
9/30/2024$ 102.25M
6/30/2024$ 102.63M
3/31/2024$ 1.71M
12/31/2023$ 21.04M
9/30/2023$ 20.7M
6/30/2023$ 20.4M
3/31/2023$ 19.96M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ENTRADA THERAPEUTICS INC's latest trailing twelve months (TTM) CF - Financing stands at $ 50.09M.
  • Over the past 5 years, ENTRADA THERAPEUTICS INC's average CF - Financing has been $ 82.44M.
  • The median CF - Financing for ENTRADA THERAPEUTICS INC during this period was $ 50.09M
  • ENTRADA THERAPEUTICS INC reached its highest CF - Financing over the past 5 years at $ 307.46M.
  • The lowest CF - Financing recorded by ENTRADA THERAPEUTICS INC in the same timeframe $ 479K

ENTRADA THERAPEUTICS INC's CF - Financing vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Financing Benchmarks
CompanyCF - Financing
ALEC : ALECTOR INC $ 9.91MSGMO : SANGAMO THERAPEUTICS INC $ 43.54MENTA : ENANTA PHARMACEUTICALS INC $ -25.51MADCT : ADC THERAPEUTICS SA $ 92.06MCDXS : CODEXIS INC $ 59.3MBDTX : BLACK DIAMOND THERAPEUTICS INC $ -45KSCPH : SCPHARMACEUTICALS INC $ 68.19MTHTX : THERATECHNOLOGIES INC $ -16.64MEDIT : EDITAS MEDICINE INC $ 61.49MFENC : FENNEC PHARMACEUTICALS INC $ -12.66M

Definition of Net Cash Flow - Financing

[Cash Flow Statement] The amount of cash inflow (outflow) from financing activities. Financing activities include issuance (purchase) of equity shares, issuance (repayment) of debt, and the payment of dividends.

TRDA - Net Cash Flow - Financing, Last 5 years

$ 479K

Minimum

Dec 31, 2022

$ 307.46M

Maximum

Dec 31, 2021

$ 82.44M

Average

$ 50.09M

Median

CF - Financing Benchmark Analysis

The chart above depicts the distribution of CF - Financing for companies in the Total Stock Market. The average CF - Financing of the companies is $ -6.74M with a standard deviation of $ 119.11M.
The following table provides additional summary stats:
CF - Financing in the Market:
filtered constituents3.23K
min$ -367.1M
max$ 366M
average$ -6.74M
median$ 314K
std$ 119.11M